Chemotherapy-induced Peripheral Neuropathy clinical trials
Access comprehensive clinical trial information for Chemotherapy-induced Peripheral Neuropathy through Pure Global AI's free database. This collection includes 60 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 23 trials are actively recruiting participants.
Research for Chemotherapy-induced Peripheral Neuropathy is being conducted in United States of America, Denmark, Belgium and 7+ other countries. Leading sponsors include University Hospital, Clermont-Ferrand and National University Hospital, Singapore. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 60 clinical trials studying Chemotherapy-induced Peripheral Neuropathy, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include University Hospital, Clermont-Ferrand, National University Hospital, Singapore, The Hong Kong Polytechnic University, among others.